| |
HIV-Dart: Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF)
|
| |
| |
Reported by Jules Levin
HIV Dart Dec 7-9 Las Cabos, Mexico
Bryan Baugh1, Erika Van Landuyt2, Simon Vanveggel2, Herta Crauwels2, Elisabeth Dammers2, Anja Hijzen2, Erkki Lathouwers2, Magda Opsomer2
1Janssen Research & Development LLC, Raritan, NJ, USA;
2Janssen Pharmaceutica NV, Beerse, Belgium
|
|
| |
| |
|
|
|
